Toward deep learning replacement of gadolinium in neuro-oncology: A review of contrast-enhanced synthetic MRI
Gadolinium-based contrast agents (GBCAs) have become a crucial part of MRI acquisitions in neuro-oncology for the detection, characterization and monitoring of brain tumors. However, contrast-enhanced (CE) acquisitions not only raise safety concerns, but also lead to patient discomfort, the need of...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Neuroimaging |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnimg.2023.1055463/full |